🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInsurance & AccessHSA/FSA eligibility for GLP-1 medications — tax guide

HSA/FSA eligibility for GLP-1 medications — tax guide

InsuranceTom Fri, Jun 5, 2026 at 4:01 PM 6 replies 242 viewsPage 1 of 2
InsuranceTom
Senior Member
1,345
7,890
Mar 2024
Connecticut
Jun 5, 2026 at 4:01 PM#1

This is the version of the explanation I wish somebody had given me, written down before I forget what confused me. It is about cost and coverage, and it is deliberately narrow — everything I am not confident about is marked as such.

What is actually established

Denials are usually procedural rather than clinical, and the order that works reflects that. Get the denial reason in writing, because it names the criterion you failed. Then supply the documentation that criterion asks for — usually documented BMI with a comorbidity, or a failed prior therapy. Then appeal, and ask for a peer-to-peer review, because a prescriber talking to a reviewing clinician resolves a large fraction of denials that written appeals do not. Manufacturer copay assistance is separate and applies mainly to commercial insurance, and patient assistance programmes are means-tested rather than a discount.

The condition it depends on

Coverage criteria are plan-specific rather than insurer-specific. Two people with the same insurer and different employers have different rules, which is why "my insurer covers it" is not transferable information.

What I am not sure about

What I am after is what actually works on a prior-authorisation denial, as opposed to the list of things that sound like they should work. Happy to be told the question itself is wrong.

— InsuranceTom · corrections welcome and will be edited into this post with credit
1 21lisa_labSD
Reply Quote Save Share Report
BariatricNurseD
Senior Member
1,678
7,234
Feb 2024
Dallas, TX
Online
Jun 5, 2026 at 5:13 PM#2
InsuranceTom said:
Denials are usually procedural rather than clinical, and the order that works reflects that.

Financial impact of cost and coverage weight loss beyond medication cost:

  • Groceries: SAVED $287/month (eating less)
  • Restaurants: SAVED $157/month (fewer meals out)
  • Alcohol: SAVED $107/month (stopped drinking)
  • Life insurance: Premium REDUCED by $37/month (lower BMI)
  • Copays: SAVED $57/month (fewer BP/cholesterol meds)

Net impact after medication cost: approximately BREAKING EVEN. The medication pays for itself through reduced food spending and healthcare costs. This surprised me.

50 20roxy_nash, tony_orlando, Dr.NephBHM_UK and 47 others
Reply Quote Save Share Report
Dr.PeteFamMed
Senior Member
2,012
9,234
Jan 2024
Minneapolis, MN
Jun 5, 2026 at 6:25 PM#3
InsuranceTom said:
Denials are usually procedural rather than clinical, and the order that works reflects that.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The affordability discussion here usually stops at individual tactics. At list price this class is out of reach for most of the people who would benefit, and no amount of appeal strategy changes that — it is a pricing problem wearing a paperwork costume.

Last edited: Jun 5, 2026 at 7:25 PM
49 19LindaRN_retired, tommy_boulder, hyun_seoul and 46 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
JenPlateau
Member
234
890
Nov 2024
Missouri
Jun 5, 2026 at 7:36 PM#4
Dr.PeteFamMed said:
The affordability discussion here usually stops at individual tactics.
Dr.PeteFamMed said:
...regarding the discontinuation data for cost and coverage...

I want to reframe the discontinuation narrative. We don't say "insulin fails because blood sugar rises when you stop it." We don't say "antihypertensives fail because BP goes up without them."

Why do we apply different logic to anti-obesity medications? The answer is stigma. We still, unconsciously, believe obesity is about willpower rather than biology. The discontinuation data actually PROVES it's a chronic biological condition requiring ongoing treatment.

This reframing isn't semantic — it has implications for insurance coverage, treatment duration, and patient expectations.

Last edited: Jun 6, 2026 at 1:36 AM
48 18FitDadDave, RunnerRach, TrialNerd_Beth and 45 others
Reply Quote Save Share Report
DerekSJ_a1c
Member
378
1,678
Aug 2024
San Jose, CA
Jun 6, 2026 at 2:46 AM#5
BariatricNurseD said:
Financial impact of cost and coverage weight loss beyond medication cost: Groceries: SAVED $287/month (eating less) Restaurants: SAVED $157/month…

Adding a me-too, because a thread of one person's experience is not much use.

47 17AttorneyGrant, DebRD_ATL, KristenIndy and 44 others
Reply Quote Save Share Report

Similar Threads

Prior authorization success: step-by-step guide with templates5 replies
Cigna now covering Zepbound — how I got approved13 replies
Appeal letter template — denied PA for GLP-1 medications4 replies
Mounjaro savings card — manufacturer program changes 202610 replies
Medicare Part D GLP-1 coverage — what's covered in 202610 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register